Skip to main content
The Society of Thoracic Surgeons

User account menu

  • Log in
Menu

Main navigation

  • FIGHT
    • Coping with Cancer
      • Just Diagnosed
      • In Treatment
      • In Remission
      • Survivorship
    • Cancer Information
      • Bladder Cancer
      • Blood Cancer
      • Breast Cancer
      • Head and Neck Cancer
      • Lung Cancer
      • Melanoma
      • Other
      • Latest Featured Content
      • The Archives
      • Other Resources
    • Find Clinical Trials
    • Glossary
      • Cancer FAQs
  • EDUCATE
    • Current Patient Education Video Series
      • Coronavirus and Covid 19 in the Cancer Community
      • Cancer Information for the Latino Community
      • 2020-21 Patient Education Ambassador's Program
      • Clinical Trials Experiences Through Storytelling
    • GRACE Podcasts
    • Video Library
      • English
      • Spanish
      • Mandarin
  • PARTICIPATE
    • Community Forum
      • Bladder Cancer
      • Blood Cancer
      • Brain Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Gall Bladder and Bile Duct Cancer (Cholangiocarcinoma)
      • Head and Neck Cancer
      • Kidney Cancer
      • Lung Cancer
      • Melanoma
      • Member Updates
      • General Forums
      • Ask A Question
    • Get Involved
      • Memorials and Tributes
      • Volunteer Opportunities
  • ABOUT CancerGRACE
    • GRACE NEWS AND INFO
      • Contact Us
      • How (and Why) to Use GRACE
      • GRACE Public Disclosure Documentation
    • About GRACE
      • Mission
      • Opportunities
      • Terms of Use
      • Our Supporters 2020
    • Our Team
      • Faculty
      • Staff and Board
    • Partnerships
      • GRACE and Clinical Care Options Patient Tools
      • Varian Partner Page 2020
      • Takeda Oncology Partnership Page 2020
      • Lilly Oncology Partner Page
  • DONATE
    • Why Give to GRACE
      • More Ways to Give
      • Corporate Giving Programs
      • Gifts of Stock or Securities
      • Shop and Search for the Cause
      • Create a Tribute
      • Create Your Own Fundraiser
      • Shop with GRACE

Breadcrumb

  1. Home
  2. Tagging
  3. UCLA

Immunotherapy for First Line Therapy of Advanced NSCLC

Video

Dr. Eddie Garon considers the data on immunotherapies for first line treatment of advanced NSCLC and whether we are likely to use these agents instead of or in combination with standard chemotherapy soon.

  • Read more about Immunotherapy for First Line Therapy of Advanced NSCLC

What is the Optimal Duration of Immunotherapy?

Video

UCLA Med Center's Dr. Eddie Garon discusses the open question of the optimal duration of ongoing treatment with immunotherapy for lung cancer.

  • Read more about What is the Optimal Duration of Immunotherapy?

Time to Response to Immunotherapy and the Concept of Pseudoprogression

Article

Dr. Eddie Garon reviews the pattern of response to immunotherapy in lung cancer, along with the concept of "pseudoprogression".

  • Read more about Time to Response to Immunotherapy and the Concept of Pseudoprogression

Immunotherapy Combinations: Is this the Future for Treating Lung Cancer?

Article

As we learn more about immunotherapy for lung cancer, combinations with multiple immunotherapy agents are being explored. Medical oncologist Dr. Eddie Garon considers whether combinations are likely to emerge as the leading immunotherapy approach.

  • Read more about Immunotherapy Combinations: Is this the Future for Treating Lung Cancer?

Should PD-L1 be Used as a Biomarker for Immunotherapy in Lung Cancer?

Article

Dr. Eddie Garon, UCLA, reviews the controversial question of whether PD-L1 expression is a reliable enough biomarker to be used to select patients to receive or not receive immune checkpoint inhibitor therapy in lung cancer.

  • Read more about Should PD-L1 be Used as a Biomarker for Immunotherapy in Lung Cancer?

Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer

Article

Immune checkpoint inhibitors are now becoming approved and commercially available for patients with previously treated advanced NSCLC. Dr. Eddie Garon, medical oncologist at UCLA, summarizes key data and explains their current role in treatment.

  • Read more about Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer

Immunotherapy for Lung Cancer: General Concepts

Article

Dr. Eddie Garon from UCLA Medical Center reviews the general mechanism of action of immune checkpoint inhibitors and how they can be an effective therapy in lung cancer.

  • Read more about Immunotherapy for Lung Cancer: General Concepts

MK-3475 and its Efficacy in Lung Cancer

Article

Dr. Edward Garon discusses what researchers are learning about MK-3475, an immune therapy treatment currently in clinical trial. February 2014. 

[powerpress]

  • Read more about MK-3475 and its Efficacy in Lung Cancer

How Do the Different Immune Checkpoint Inhibitors in Lung Cancer Compare?

Article

Dr. Edward Garon warns that it is still too early to compare which immune therapies will be more effective in treating lung cancer.February 2014.

[powerpress]

  • Read more about How Do the Different Immune Checkpoint Inhibitors in Lung Cancer Compare?

ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC by Dr. Edward Garon

Article

MPDL3280A Target PD-L1 Is Broadly Expressed in NSCLCDr. Edward Garon, David Geffen School of Medicine at UCLA, covers the provocative results of the novel immune checkpoint PD-L1 inhibitor MPDL3280A in advanced NSCLC.

 

[powerpress]

  • Read more about ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC by Dr. Edward Garon

Pagination

  • Page 1
  • Next page ››
Subscribe to UCLA

Stay In touch

NEWSLETTER SIGN UP

MISSIONDONATEDISCLAIMERRESOURCES

Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock

  • Log in
  • FIGHT
    • Coping with Cancer
      • Just Diagnosed
      • In Treatment
      • In Remission
      • Survivorship
    • Cancer Information
      • Bladder Cancer
      • Blood Cancer
      • Breast Cancer
      • Head and Neck Cancer
      • Lung Cancer
      • Melanoma
      • Other
      • Latest Featured Content
      • The Archives
      • Other Resources
    • Find Clinical Trials
    • Glossary
      • Cancer FAQs
  • EDUCATE
    • Current Patient Education Video Series
      • Coronavirus and Covid 19 in the Cancer Community
      • Cancer Information for the Latino Community
      • 2020-21 Patient Education Ambassador's Program
      • Clinical Trials Experiences Through Storytelling
    • GRACE Podcasts
    • Video Library
      • English
      • Spanish
      • Mandarin
  • PARTICIPATE
    • Community Forum
      • Bladder Cancer
      • Blood Cancer
      • Brain Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Gall Bladder and Bile Duct Cancer (Cholangiocarcinoma)
      • Head and Neck Cancer
      • Kidney Cancer
      • Lung Cancer
      • Melanoma
      • Member Updates
      • General Forums
      • Ask A Question
    • Get Involved
      • Memorials and Tributes
      • Volunteer Opportunities
  • ABOUT CancerGRACE
    • GRACE NEWS AND INFO
      • Contact Us
      • How (and Why) to Use GRACE
      • GRACE Public Disclosure Documentation
    • About GRACE
      • Mission
      • Opportunities
      • Terms of Use
      • Our Supporters 2020
    • Our Team
      • Faculty
      • Staff and Board
    • Partnerships
      • GRACE and Clinical Care Options Patient Tools
      • Varian Partner Page 2020
      • Takeda Oncology Partnership Page 2020
      • Lilly Oncology Partner Page
  • DONATE
    • Why Give to GRACE
      • More Ways to Give
      • Corporate Giving Programs
      • Gifts of Stock or Securities
      • Shop and Search for the Cause
      • Create a Tribute
      • Create Your Own Fundraiser
      • Shop with GRACE